Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSIGT.L Regulatory News (SIGT)

  • There is currently no data for SIGT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

9 Feb 2017 10:44

RNS Number : 4547W
Seneca Global Income & Growth PLC
09 February 2017
 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Seneca Global Income & Growth Trust plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

Yes

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

No

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

No

An event changing the breakdown of voting rights

No

Other (please specify):

No

3. Full name of person(s) subject to thenotification obligation: iii

Seneca IM Limited

4. Full name of shareholder(s)  (if different from 3.):iv

See section 9 below

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

08/02/2017

6. Date on which issuer notified:

09/02/2017

7. Threshold(s) that is/are crossed orreached: vi, vii

Was 5.31%, Now 4.81%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB0008769993

2,119,989

2,119,989

1,919,989

n/a

1,919,989

n/a

4.81%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

n/a

n/a

n/a

n/a

n/a

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

1,919,989

4.81%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

Segregated Account

Bank of New York Nominees Ltd a/c 318901

250,011

CF Seneca Diversified Income Fund

Bank of New York Nominees Ltd a/c 392513

1,669,978

Proxy Voting:

10. Name of the proxy holder:

n/a

11. Number of voting rights proxy holder will cease to hold:

n/a

12. Date on which proxy holder will cease to hold voting rights:

n/a

13. Additional information:

14. Contact name:

Steven Cowie

15. Contact telephone number:

0131 538 1400

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUKSRRBRAURAR
Date   Source Headline
11th Aug 202012:06 pmRNSNet Asset Value(s)
10th Aug 20204:41 pmRNSTransaction in Own Shares
10th Aug 202012:13 pmRNSNet Asset Value(s)
7th Aug 20204:48 pmRNSTransaction in Own Shares
7th Aug 202012:25 pmRNSNet Asset Value(s)
6th Aug 202012:38 pmRNSNet Asset Value(s)
5th Aug 20204:43 pmRNSTransaction in Own Shares
5th Aug 20201:31 pmRNSUpdate research from QuotedData
5th Aug 202012:41 pmRNSNet Asset Value(s)
4th Aug 20204:58 pmRNSTransaction in Own Shares
4th Aug 202012:47 pmRNSNet Asset Value(s)
3rd Aug 202012:54 pmRNSNet Asset Value(s)
3rd Aug 202010:55 amRNSTotal Voting Rights
31st Jul 202012:58 pmRNSNet Asset Value(s)
30th Jul 20204:45 pmRNSTransaction in Own Shares
30th Jul 202012:27 pmRNSNet Asset Value(s)
29th Jul 202012:15 pmRNSNet Asset Value(s)
28th Jul 20205:02 pmRNSTransaction in Own Shares
28th Jul 202012:05 pmRNSNet Asset Value(s)
27th Jul 202012:19 pmRNSNet Asset Value(s)
24th Jul 20205:16 pmRNSTransaction in Own Shares
24th Jul 202012:16 pmRNSNet Asset Value(s)
23rd Jul 202011:11 amRNSNet Asset Value(s)
22nd Jul 20205:10 pmRNSTransaction in Own Shares
22nd Jul 202011:29 amRNSNet Asset Value(s)
21st Jul 20201:10 pmRNSResult of AGM
21st Jul 202012:05 pmRNSNet Asset Value(s)
20th Jul 20204:53 pmRNSTransaction in Own Shares
20th Jul 202011:23 amRNSNet Asset Value(s)
17th Jul 20205:08 pmRNSTransaction in Own Shares
17th Jul 20201:21 pmRNSNet Asset Value(s)
16th Jul 20205:21 pmRNSTransaction in Own Shares
16th Jul 202012:06 pmRNSNet Asset Value(s)
15th Jul 20204:29 pmRNSTransaction in Own Shares
15th Jul 202012:28 pmRNSNet Asset Value(s)
14th Jul 20205:05 pmRNSTransaction in Own Shares
14th Jul 202012:52 pmRNSNet Asset Value(s)
13th Jul 202012:56 pmRNSNet Asset Value(s)
10th Jul 20205:42 pmRNSTransaction in Own Shares
10th Jul 202012:36 pmRNSNet Asset Value(s)
9th Jul 20204:59 pmRNSTransaction in Own Shares
9th Jul 202012:40 pmRNSNet Asset Value(s)
8th Jul 20201:54 pmRNSNet Asset Value(s)
7th Jul 202012:48 pmRNSNet Asset Value(s)
6th Jul 20204:57 pmRNSTransaction in Own Shares
6th Jul 20201:56 pmRNSNet Asset Value(s)
3rd Jul 20205:19 pmRNSTransaction in Own Shares
3rd Jul 20201:42 pmRNSNet Asset Value(s)
2nd Jul 20202:17 pmRNSNet Asset Value(s)
1st Jul 20205:10 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.